Skip to main content
. 2017 Sep 12;9:292. doi: 10.3389/fnagi.2017.00292

Figure 3.

Figure 3

Low frequency-rTMS reduces neuritic plaques, β-site APP-cleaving enzyme 1 (BACE1), amyloid-β precursor protein (APP) and its C-terminal fragments (CTFs) in AD mice. (A,B) Low-frequency rTMS decreases neuritic plaque formation (arrows). Scale bar: 500 μm. (C) Sequential immunoblotting of total tissue lysates of hippocampal tissues collected from animals after behavioral tests. (D) The relative protein level is normalized by the AD group. **p < 0.01, *p < 0.05.